Péter Reményi

1.1k total citations
44 papers, 400 citations indexed

About

Péter Reményi is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Péter Reményi has authored 44 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Péter Reményi's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Péter Reményi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Péter Reményi collaborates with scholars based in Hungary, Germany and Italy. Péter Reményi's co-authors include Tamás Masszi, Árpád Bátai, Hajnalka Andrikovics, András Bors, Attila Tordai, Judit Csomor, János Sinkó, Katalin Pálóczi, E Kelemen and Marienn Réti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Péter Reményi

38 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Reményi Hungary 13 228 135 100 89 64 44 400
Amine Belhabri France 14 272 1.2× 112 0.8× 147 1.5× 95 1.1× 33 0.5× 40 458
Emily Farrell Australia 10 169 0.7× 79 0.6× 51 0.5× 80 0.9× 54 0.8× 20 475
Naofumi Matsuno Japan 12 386 1.7× 128 0.9× 107 1.1× 104 1.2× 121 1.9× 28 484
Joycelyn Sim China 9 199 0.9× 117 0.9× 100 1.0× 57 0.6× 45 0.7× 19 292
Toshiro Kawakita Japan 11 319 1.4× 91 0.7× 90 0.9× 75 0.8× 105 1.6× 77 504
Evelyne D’Incan France 10 311 1.4× 88 0.7× 119 1.2× 98 1.1× 51 0.8× 23 410
Léonardo Magro France 11 270 1.2× 116 0.9× 75 0.8× 119 1.3× 105 1.6× 43 469
AH Elmaagacli Germany 13 413 1.8× 156 1.2× 90 0.9× 95 1.1× 66 1.0× 15 531
Keiren Kirkland United Kingdom 11 297 1.3× 105 0.8× 84 0.8× 162 1.8× 86 1.3× 24 458
Carla Filì Italy 10 310 1.4× 63 0.5× 104 1.0× 52 0.6× 90 1.4× 24 436

Countries citing papers authored by Péter Reményi

Since Specialization
Citations

This map shows the geographic impact of Péter Reményi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Reményi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Reményi more than expected).

Fields of papers citing papers by Péter Reményi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Reményi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Reményi. The network helps show where Péter Reményi may publish in the future.

Co-authorship network of co-authors of Péter Reményi

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Reményi. A scholar is included among the top collaborators of Péter Reményi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Reményi. Péter Reményi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Bors, András, László Gopcsa, Gábor Mikala, et al.. (2021). Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia. PLoS ONE. 16(6). e0253386–e0253386. 6 indexed citations
5.
Reményi, Péter, et al.. (2020). Hidden geographies of population implosion in Bosnia and Herzegovina. SHILAP Revista de lepidopterología. 11(2). 47–64. 6 indexed citations
6.
7.
Tordai, Attila, András Bors, Hajnalka Andrikovics, et al.. (2019). Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning. PLoS ONE. 14(6). e0218945–e0218945. 8 indexed citations
8.
Andrikovics, Hajnalka, Péter Reményi, Árpád Bátai, et al.. (2015). The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy. Bone Marrow Transplantation. 50(10). 1321–1325. 18 indexed citations
9.
Pap, Norbert, et al.. (2014). Human Resource Development As A Possibility For Developing The Most Underdeveloped Microregions Of Hungary1. RePEc: Research Papers in Economics. 10. 931–942. 1 indexed citations
10.
Andrikovics, Hajnalka, András Bors, Magdalena Koszarska, et al.. (2014). Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations. Haematologica. 99(7). 1184–1190. 63 indexed citations
11.
Reményi, Péter, László Gopcsa, Marienn Réti, et al.. (2014). Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF. Advances in Therapy. 31(4). 451–460. 20 indexed citations
12.
Wagner, László, Gábor Mikala, Péter Reményi, et al.. (2013). Successful Treatment of Renal Failure Caused by Multiple Myeloma With HLA-Identical Living Kidney and Bone Marrow Transplantation: A Case Report. Transplantation Proceedings. 45(10). 3705–3707. 8 indexed citations
13.
Koszarska, Magdalena, András Bors, Árpád Bátai, et al.. (2013). Medium-sizedFLT3internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort. Leukemia & lymphoma. 55(7). 1510–1517. 15 indexed citations
14.
15.
Sinkó, János, et al.. (2007). Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy‐driven survey. Transplant Infectious Disease. 10(2). 106–109. 38 indexed citations
16.
Bátai, Árpád, E Kelemen, Péter Reményi, et al.. (2000). Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state. Human Immunology. 61(2). 101–110. 13 indexed citations
17.
18.
Reményi, Péter, et al.. (1997). Value of surveillance cultures in a bone marrow transplantation unit. Journal of Medical Microbiology. 46(9). 785–791. 12 indexed citations
19.
Pócsik, Éva, Béla Z. Schmidt, Péter Reményi, et al.. (1995). Immunophenotypic and Functional Characteristics of Haemopoietic Cells from Human Cord Blood. Scandinavian Journal of Immunology. 42(4). 493–500. 12 indexed citations
20.
Bátai, Árpád, et al.. (1994). Molecular background of a new case of chronic myelogenous leukemia with bcr-abl chimera mRNA lacking the A2 exon.. PubMed. 8(10). 1791–1791. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amine Belhabri Breakdown of academic impact, for papers by Emily Farrell Breakdown of academic impact, for papers by Naofumi Matsuno Breakdown of academic impact, for papers by Joycelyn Sim Breakdown of academic impact, for papers by Toshiro Kawakita Breakdown of academic impact, for papers by Evelyne D’Incan Breakdown of academic impact, for papers by Léonardo Magro Breakdown of academic impact, for papers by AH Elmaagacli Breakdown of academic impact, for papers by Keiren Kirkland Breakdown of academic impact, for papers by Carla Filì
Rankless by CCL
2026